US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
Milei Threatens Falkland Oil Firms With Sanctions 
OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
South Korea, US Discuss Chip Investments Amid Tariff Plans 
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada 
France Targets Shein, Temu With Fast-Fashion Fees 
Lynas Rare Earths Shares Rise After Takeover Talks Revealed 
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus 
Qantas Near-Miss Raises Sydney Air Traffic Controller Fatigue Concerns 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses 
Xiaomi Shares Jump on Europe EV Expansion Plan 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
CATL Shares Fall as Hungary Plant Faces Safety Halt 
Add as a preferred source on Google
GAITHERSBURG, Md., March 05, 2018 -- OpGen, Inc. (NASDAQ:OPGN) announced today that the Company will report its fourth quarter and fiscal year 2017 financial results after close of market on Thursday, March 15, 2018. OpGen’s management team will host a live conference call and webcast at 4:30 p.m. Eastern time to discuss the Company’s financial results and business progress.
Dial-in Information
U.S. Dial-In Number: (888) 883-4599
International Dial-In Number: (484) 653-6821
Conference ID: 8899787
Replay Dial-in Information
U.S. Dial-In Number: (855) 859-2056
International Dial-In Number: (404) 537-3406
Conference ID: 8899787
Following the conclusion of the conference call, a replay will be available through March 22, 2018. The live, listen-only webcast of the conference call may also be accessed by visiting the investors section of the Company’s website at http://ir.opgen.com. A replay of the webcast will be available after the conclusion of the call and will be archived on the Company’s website for 90 days.
About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection treatment and prevention. Learn more at www.opgen.com and follow OpGen on Twitter and LinkedIn.
OpGen, Acuitas, and Acuitas Lighthouse are registered trademarks of OpGen, Inc. All other trademarks are properties of their respective owners.
OpGen Contact:
Michael Farmer
Sr. Director, Marketing
240-813-1284
[email protected]
[email protected]
Investor Contacts:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
[email protected]
or
Bruce Voss
310-691-7100
[email protected]
